awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33407093-6E1AC4D0-EF8F-4E81-9036-4227ED661552
Q33407093-6E1AC4D0-EF8F-4E81-9036-4227ED661552
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33407093-6E1AC4D0-EF8F-4E81-9036-4227ED661552
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.
P2860
Q33407093-6E1AC4D0-EF8F-4E81-9036-4227ED661552
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33407093-6E1AC4D0-EF8F-4E81-9036-4227ED661552
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d41c43ec662d82567181758d7f41fc7b562fe9a
P2860
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.